Administrative Core
Administrative Core
批准号:
10221082
负责人:
Corinne Mary Linardic
金额:
$3.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-11 至 2024-08-31
关键词:
AdministratorAdvocateAffectAlveolar RhabdomyosarcomaAnnual ReportsBiologyCalendarChildChimeric ProteinsCollaborationsCommunicationCommunitiesDataDecision MakingDevelopmentDoctor of PhilosophyEducational workshopEnsureEvaluationExpenditureExperimental DesignsFOXO1A geneFeedbackFinancial SupportFosteringGoalsHuman ResourcesIn VitroInfrastructureInstitutional PolicyLaboratoriesLeadLeadershipLinkLogisticsMalignant Childhood NeoplasmMalignant NeoplasmsMolecular TargetMonitorOccupational activity of managing financesOncogenicPAX3 genePatientsPoliciesProblem SolvingProcessProteinsPublicationsPublishingRegulationReportingReproducibilityResearchResearch PersonnelResource SharingRhabdomyosarcomaRiskScienceScientific EvaluationScientistTechnologyTherapeuticTimeUnited States National Institutes of HealthValidationVertebratesWorkcandidate validationcareer developmentdata sharingexperienceexperimental studyhigh standardhuman subjectin vivomeetingsmembermultidisciplinarynew technologynovel strategiesoutreachprogramstreatment strategyweb siteworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – Administrative Core
Fusion-positive alveolar rhabdomyosarcoma (ARMS) remains one of the most fatal but least understood cancers
of childhood. Despite the 1993 identification of the PAX3-FOXO1 fusion protein as a key oncogenic driver of
ARMS, treatment strategies for affected children remain unchanged. Thus the overarching goal of this FusOnC2
Center is to advance the therapeutic tractability of the PAX3-FOXO1 fusion protein in ARMS by comprehensively
identifying the druggable co-regulators, modulators, and intrinsic activities of PAX3-FOXO1. In support of this,
the Administrative Core will provide leadership, oversight, coordination, integration, dissemination and evaluation
for the Center and connect it to the NCI FusOnC2 Consortium. Given our multi-disciplinary, multi-institutional
team, these activities will enhance scientific rigor and accelerate our collective progress. Overall PIs Corinne
Linardic, MD, PhD, and Christopher Counter, PhD will lead this Core, supported by the Executive Committee,
Scientific Advisory Board (SAB), and administrative staff, including an experienced Center Administrator and an
expert Financial Manager. Drs. Linardic and Counter, and the Executive Committee also will work closely with
the NCI Program Officer, Project Scientist, and FusOnC2 Consortium Steering Committee regarding Center
plans and direction. The Administrative Core proposes the following Specific Aims: 1) Provide organizational and
logistical support for component activities; 2) Coordinate and enhance interactions among Center components;
3) Provide financial management and ensure fiscal and regulatory compliance; 4) Monitor scientific progress and
scientific rigor; 5) Disseminate discoveries and collaborate; and 6) Establish mechanisms for internal and
external review. Through the Center Executive Committee’s regular meetings, the Core will manage, coordinate,
and integrate scientific activities across the Projects and Cores, provide transparency in decision-making, and
facilitate participation in FusOnC2 Consortium activities. In addition to the Executive Committee meetings, the
Administrative Core will coordinate meetings of a “Quantitative Sciences Working Group” to provide a layer of
cross-Project data review and transparency, and to identify and ameliorate risks, including analyses that need
to be confirmed or replicated by others, thus helping to ensure reproducibility. In conjunction with the FusOnC2
Consortium Steering Committee, the Administrative Core will develop and implement policies for timely data
sharing and publication. The Administrative Core will serve as the “hub” for our Center’s activities to accelerate
progress and enhance rigor, and as the link to other FusOnC2 Centers for development and conduct of
collaborative Consortium projects. Through our outreach plan, the Core will nurture trainees’ career development
and promote data and resource sharing. This Center is committed to full participation in FusOnC2 Consortium
activities, and the research team welcomes this opportunity to apply ambitious new technologies and approaches
to solve the problem of fusion protein-fueled cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining and targeting the PAX3-FOXO1 interactome
-
批准号:10902753
-
项目类别:
-
资助金额:$15.77万
-
财政年份:2023
-
负责人:Corinne Mary Linardic
-
依托单位:
Chemical probe discovery for PAX3-FOXO1
-
批准号:10680802
-
项目类别:
-
资助金额:$19.59万
-
财政年份:2022
-
负责人:Corinne Mary Linardic
-
依托单位:
Defining and targeting the PAX3-FOXO1 interactome
-
批准号:10680800
-
项目类别:
-
资助金额:$17.35万
-
财政年份:2022
-
负责人:Corinne Mary Linardic
-
依托单位:
Duke Center for Advancement of Child Health (CAtCH)
-
批准号:10225061
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2021
-
负责人:Corinne Mary Linardic
-
依托单位:
Duke Center for Advancement of Child Health (CAtCH)
-
批准号:10375590
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2021
-
负责人:Corinne Mary Linardic
-
依托单位:
Duke Center for Advancement of Child Health (CAtCH)
-
批准号:10610966
-
项目类别:
-
资助金额:$17.78万
-
财政年份:2021
-
负责人:Corinne Mary Linardic
-
依托单位:
Administrative Core
-
批准号:10221087
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2020
-
负责人:Corinne Mary Linardic
-
依托单位:
Molecular Modeling of Pediatric Skeletal Muscle Tumors
-
批准号:7751314
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2009
-
负责人:Corinne Mary Linardic
-
依托单位:
Molecular Modeling of Pediatric Skeletal Muscle Tumors
-
批准号:8196840
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2009
-
负责人:Corinne Mary Linardic
-
依托单位:
Molecular Modeling of Pediatric Skeletal Muscle Tumors
-
批准号:7580818
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2009
-
负责人:Corinne Mary Linardic
-
依托单位:
Molecular Modeling of Pediatric Skeletal Muscle Tumors
-
批准号:8385551
-
项目类别:
-
资助金额:$26.56万
-
财政年份:2009
-
负责人:Corinne Mary Linardic
-
依托单位:
Molecular Modeling of Pediatric Skeletal Muscle Tumors
-
批准号:7996023
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2009
-
负责人:Corinne Mary Linardic
-
依托单位:
海外基金